BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9736341)

  • 1. Stimulation of the high-affinity IgE receptor results in the tyrosine phosphorylation of a 60 kD protein which is associated with the protein-tyrosine kinase, Csk.
    Rafnar T; Peebles RS; Brummet ME; Catipović B; Imani F; MacGlashan DW; Marsh DG
    Mol Immunol; 1998 Mar; 35(4):249-57. PubMed ID: 9736341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
    Potuckova L; Draberova L; Halova I; Paulenda T; Draber P
    Front Immunol; 2018; 9():1771. PubMed ID: 30116247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.
    Neet K; Hunter T
    Mol Cell Biol; 1995 Sep; 15(9):4908-20. PubMed ID: 7544435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SH2 domain-mediated targeting, but not localization, of Syk in the plasma membrane is critical for FcepsilonRI signaling.
    Sada K; Zhang J; Siraganian RP
    Blood; 2001 Mar; 97(5):1352-9. PubMed ID: 11222380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Csk is constitutively associated with a 60-kDa tyrosine-phosphorylated protein in human T cells.
    Catipović B; Schneck JP; Brummet ME; Marsh DG; Rafnar T
    J Biol Chem; 1996 Apr; 271(16):9698-703. PubMed ID: 8621646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting Edge: Transmembrane phosphoprotein Csk-binding protein/phosphoprotein associated with glycosphingolipid-enriched microdomains as a negative feedback regulator of mast cell signaling through the FcepsilonRI.
    Ohtake H; Ichikawa N; Okada M; Yamashita T
    J Immunol; 2002 Mar; 168(5):2087-90. PubMed ID: 11859092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of C-terminal Src kinase in the initiation and the termination of the high affinity IgE receptor-mediated signaling.
    Honda Zi; Suzuki T; Hirose N; Aihara M; Shimizu T; Nada S; Okada M; Ra C; Morita Y; Ito K
    J Biol Chem; 1997 Oct; 272(41):25753-60. PubMed ID: 9325302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation.
    Kovárová M; Tolar P; Arudchandran R; Dráberová L; Rivera J; Dráber P
    Mol Cell Biol; 2001 Dec; 21(24):8318-28. PubMed ID: 11713268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
    Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of Csk in signal transduction through the B-cell antigen receptor.
    Hata A; Sabe H; Kurosaki T; Takata M; Hanafusa H
    Mol Cell Biol; 1994 Nov; 14(11):7306-13. PubMed ID: 7935444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets.
    Hirao A; Hamaguchi I; Suda T; Yamaguchi N
    EMBO J; 1997 May; 16(9):2342-51. PubMed ID: 9171348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils.
    Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM
    J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupled motions in the SH2 and kinase domains of Csk control Src phosphorylation.
    Wong L; Lieser SA; Miyashita O; Miller M; Tasken K; Onuchic JN; Adams JA; Woods VL; Jennings PA
    J Mol Biol; 2005 Aug; 351(1):131-43. PubMed ID: 16002086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling.
    Kazi JU; Vaapil M; Agarwal S; Bracco E; Påhlman S; Rönnstrand L
    Cell Signal; 2013 Sep; 25(9):1852-60. PubMed ID: 23707526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae.
    Murphy SM; Bergman M; Morgan DO
    Mol Cell Biol; 1993 Sep; 13(9):5290-300. PubMed ID: 7689149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Csk homologous kinase, Chk, binds tyrosine phosphorylated paxillin in human blastic T cells.
    Grgurevich S; Mikhael A; McVicar DW
    Biochem Biophys Res Commun; 1999 Mar; 256(3):668-75. PubMed ID: 10080957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein tyrosine kinase syk activity is reduced by clustering the mast cell function-associated antigen.
    Xu R; Pecht I
    Eur J Immunol; 2001 May; 31(5):1571-81. PubMed ID: 11465115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
    McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
    Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
    Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
    Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.